Bad-deficient mice develop diffuse large B cell lymphoma
AUTOR(ES)
Ranger, Ann M.
FONTE
National Academy of Sciences
RESUMO
The proapoptotic activity of the “BH3-only” molecule BAD can be differentially regulated by survival factor signaling. Bad-deficient mice lacking both BAD long and BAD short proteins proved viable, and most cell types appeared to develop normally. BAD did not exclusively account for cell death after withdrawal of survival factors, but it was an intermediate for epidermal growth factor- or insulin-like growth factor I-countered apoptosis, consistent with a “sensitizing” BH3-only molecule. Lymphocytes developed normally with no premalignant hyperplasia, but they displayed subtle abnormalities in proliferation and IgG production. Despite the minimal phenotype, Bad-deficient mice progressed, with aging, to diffuse large B cell lymphoma of germinal center origin. Exposure of Bad-null mice to sublethal γ-irradiation resulted in an increased incidence of pre-T cell and pro-/pre-B cell lymphoblastic leukemia/lymphoma. Thus, proapoptotic BAD suppresses tumorigenesis in the lymphocyte lineage.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=170917Documentos Relacionados
- Pathophysiology and molecular aspects of diffuse large B-cell lymphoma
- Results of CHOP chemotherapy for diffuse large B-cell lymphoma
- Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
- Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
- CD5‐positive diffuse large B cell lymphoma arising from a CD5‐positive follicular lymphoma
